Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease, and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Researchers found that regular coffee or caffeine intake, especially at moderate levels, was associated...
The seasons are a-changing, with fall coming to those of us in the northern hemisphere and springtime to our members and friends in the southern hemisphere. It’s a wonderful time of year, as students in the north return to class, and students in the south start to look forward to summer vacation. For many colleagues,...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Study Data Support Efficacy of Treatment for Vasomotor Symptoms Associated with Menopause As reported in the Sept. 6 Pharma Fridays, Bayer will present detailed results from the Phase III study OASIS 3, providing supporting efficacy data and sustained safety data over...
Despite the reasons for pursuing medicine as a career, there will always be speed bumps that can lead to frustration, stress, burnout, or even a career or job change. Michael Morkos, MD, offers some tips on navigating the challenging and often confusing world of medical billing. Many of us decided to pursue medicine for a...
Girls exposed to certain endocrine-disrupting chemicals (EDCs) may be more likely to start puberty early, according to new research published in Endocrinology, the flagship basic science journal of the Endocrine Society. EDCs mimic, block or interfere with hormones in the body’s endocrine system. There has been an alarming trend toward early puberty in girls, suggesting the influence of...
Monica M. Laronda, PhD, and Jane E. Reusch, MD, have long been leading advocates for the importance of equity in scientific research, specifically as it relates to women’s health. As they engage with national initiatives focusing on how this research is funded, they spoke to Endocrine News to discuss the latest in these efforts, their...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Glytec Expands Global Collaboration with Roche to Revolutionize Hospital Diabetes Management Transforming Global Hospital Diabetes Management On August 27, Glytec, announced an expansion of its collaboration with Roche, that will allow the use of Glytec’s software in connection with Roche’s smart-device...
Women with higher levels of per- and polyfluoroalkyl substances (PFAS) during pregnancy may experience long-term weight gain and heart problems later in life, according to new research published in The Journal of Clinical Endocrinology & Metabolism. PFAS are manmade chemicals found in food packaging, cookware, clothes, drinking water, personal care products and many other consumer goods. These endocrine-disrupting...